中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2013年
13期
20-21
,共2页
莫俊德%钟国荣%李元塔%王磊
莫俊德%鐘國榮%李元塔%王磊
막준덕%종국영%리원탑%왕뢰
慢性肺心病%心力衰竭%贝那普利
慢性肺心病%心力衰竭%貝那普利
만성폐심병%심력쇠갈%패나보리
Chronic pulmonary heart disease%Heart failure%Benazepril
目的 探讨慢性肺心痛并发心力衰竭的临床药物治疗方法.方法 选取湛江中心人民医院收治的慢性肺心病并发心力衰竭患者90例,将其随机分为观察组和对照组,对照组给予抗感染、消炎、吸氧、利尿以及纠正电解质紊乱等常规治疗,观察组在对照组基础上给予口服贝那普利,治疗2个疗程后观察两组患者的心功能改变情况以及不良反应情况.结果 观察组总有效率(93.33％)明显高于对照组(66.67％),且心功能改善情况明显优于对照组,观察组pH和PaO2上升程度和PaCO2下降程度明显大于对照组,两组对比差异均有统计学意义(P＜0.05).观察组出现6例不良反应,对照组未出现不良反应.结论 在常规治疗的基础上给予贝那普利治疗慢性肺心病并发心力衰竭可有效改善患者的心功能,且不良反应少均可耐受.
目的 探討慢性肺心痛併髮心力衰竭的臨床藥物治療方法.方法 選取湛江中心人民醫院收治的慢性肺心病併髮心力衰竭患者90例,將其隨機分為觀察組和對照組,對照組給予抗感染、消炎、吸氧、利尿以及糾正電解質紊亂等常規治療,觀察組在對照組基礎上給予口服貝那普利,治療2箇療程後觀察兩組患者的心功能改變情況以及不良反應情況.結果 觀察組總有效率(93.33％)明顯高于對照組(66.67％),且心功能改善情況明顯優于對照組,觀察組pH和PaO2上升程度和PaCO2下降程度明顯大于對照組,兩組對比差異均有統計學意義(P＜0.05).觀察組齣現6例不良反應,對照組未齣現不良反應.結論 在常規治療的基礎上給予貝那普利治療慢性肺心病併髮心力衰竭可有效改善患者的心功能,且不良反應少均可耐受.
목적 탐토만성폐심통병발심력쇠갈적림상약물치료방법.방법 선취담강중심인민의원수치적만성폐심병병발심력쇠갈환자90례,장기수궤분위관찰조화대조조,대조조급여항감염、소염、흡양、이뇨이급규정전해질문란등상규치료,관찰조재대조조기출상급여구복패나보리,치료2개료정후관찰량조환자적심공능개변정황이급불량반응정황.결과 관찰조총유효솔(93.33％)명현고우대조조(66.67％),차심공능개선정황명현우우대조조,관찰조pH화PaO2상승정도화PaCO2하강정도명현대우대조조,량조대비차이균유통계학의의(P＜0.05).관찰조출현6례불량반응,대조조미출현불량반응.결론 재상규치료적기출상급여패나보리치료만성폐심병병발심력쇠갈가유효개선환자적심공능,차불량반응소균가내수.
Objective To investigate the clinical medication treatment of chronic pulmonary heart disease with heart failure.Methods Ninety cases of chronic pulmonary heart disease with heart failure were selected,which were randomly divided into observation group and control group,patients in control group were given conventional treatment such as anti-infection,diminish inflammation,oxygen,diuresis and correct electrolyte disorder,patients in observation group were given oral benazepril based on the treatment of control group.After 2 courses of treatment,the cardiac function change condition and adverse reaction conditions were observed.Results The total effective rate of observation group (93.33％) was much higher than that of the control group(66.67％),and improvement of heart function was obviously superior to the control group,the pH and PaO2 rising degree and PaCO2 decreasing degree of observation group was significantly greater than those in control group,the differences between the two groups were significant (P ＜ 0.05).In the observation group,6 cases had adverse reactions,while no adverse reaction occurred in control group.Conclusions Benazepril on the basis of conventional treatment in the treatment of chronic pulmonary heart disease combined with heart failure can effectively improve cardiac function of patients,and has less adverse reactions,all patients can tolerate.
